AIM bulletins from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
GreenRoc draws EUR 0.85m from loan facility for Amitsoq development
Mon 08 December 2025 15:03
(Sharecast News) - GreenRoc Strategic Materials announced on Monday that it has drawn down €0.85m from its loan facility with Denmark's Export and Investment Fund to support the next phase of development at its Amitsoq graphite project in Greenland, and
Block Energy gets farm-in proposal for Georgia's Project III
Mon 08 December 2025 14:59
(Sharecast News) - Block Energy announced on Monday that it had received a non-binding farm-in proposal for its Project III gas interests in Georgia, offering to fund appraisal and early development work at the Patardzueli-Samgori field.
Rockfire reports progress at Molaoi zinc project
Mon 08 December 2025 14:06
(Sharecast News) - Rockfire Resources reported progress at its Molaoi zinc project in Greece on Monday, where drilling of the third hole in the current campaign was advancing and had reached a depth of 140 metres as of early 8 December.
Hercules shares pop on £6.2m of new contract awards
Mon 08 December 2025 14:01
(Sharecast News) - Hercules announced a series of new contract awards worth about £6.2m for its Civils Projects division on Monday, strengthening its position in the UK water sector as the industry enters a major investment cycle.
Hutchmed medicines get renewed, new reimbursement coverage in China
Mon 08 December 2025 11:50
(Sharecast News) - Hutchmed China said on Monday that several of its oncology medicines would remain covered under China's state reimbursement system next year, while another had been added to a new commercial insurance list, expanding patient access and
Proteome secures third contract from US biopharma client
Mon 08 December 2025 09:39
(Sharecast News) - Proteome Sciences announced on Monday that it has secured a third contract from a US biopharmaceutical client for its mass spectrometry services, further expanding the company's role in supporting clinical development programmes.